Search our Site

Finbar Dolan

Finbar Dolan

Finbar Dolan
2016/17

Finbar is currently CEO of VERSONO Medical Ltd., a Med Tech start-up company focused on commercialising a disruptive medical device platform technology to address a well understood unmet clinical need in the highest growth segment of the $10bn peripheral endovascular device market. Finbar further expanded his capabilities during the BioInnovate program to evaluate the viability of this novel Innovation.
BioInnovate Galway

Subscribe

* indicates required

BioInnovate Ireland will use the information you provide on this form to keep in touch with you and provide you with updates in relation to: BioInnovate Fellowship and Recruitment; BioInnovate Alumni; BioInnovate Newsletter; BioInnovate News and Events; Upcoming training and events; Funding Opportunities; Research projects. Please let us know all the ways you would like to hear from us:

You can change your mind at any time by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at info@bioinnovate.ie. We will treat your information with respect. For more information about our privacy practices please visit our website. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

BioInnovate Ireland Block E
University of Galway,
H91 TK33, Ireland +353 (0)91 492 646 Situated on the prestigious campus of  University of Galway within the medieval city of Galway, European Capital of Culture in 2020, with equal easy access to the wilderness of Connemara in the west and the European mainland in the east, BioInnovate boasts a superb location.

Our affiliation with Stanford BioDesign has helped us to become one of the world’s leading innovation hubs with an immense debt of gratitude owed to Enterprise Ireland for both their financial and professional support in helping BioInnovate grow.